Gov. Greg Abbott's speech sets a broad agenda for the Legislature, including a nuclear renaissance and a Texas Cyber Command.

Barclays (LON:BARC) analyst Matt Miksic increased the price target on Abbott Labs (NYSE:ABT) shares to $158 from $149, while reiterating an Overweight rating on the stock. The adjustment comes in ...

Abbott (ABT) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Over ...

Abbott's Q4 sales grow 7.2%, missing estimates, but analysts remain upbeat with strong 2025 projections driven by Diabetes Care and Medical Devices.

Financial analysis of Abbott Laboratories Q4 2024 results and 2025 outlook, with a 'Buy' rating due to revenue growth and EPS ...

The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.

In this article, we will take a look into Abbott Laboratories's (NYSE:ABT) DCF analysis, a reliable and data-driven approach ...

Company has SRBC & Co LLP as its auditors. As on 31-12-2024, the company has a total of 2.12 Crore shares outstanding.Abbott India Share Price Today is Rs. 26173.30. On previous day, the Abbott India ...

Abbott Laboratories ABT shares are trading at a discount to the Zacks Medical Products industry. Its trailing 12-month price-to-book value ... s average of 8.77. The stock also remains ...